Brazilian Real: Correction against US Dollar tracks rate repricing – ING
ING’s Chris Turner notes USD/BRL may move toward 5.14 as the stronger US Dollar and local political and trade risks weigh on the Brazilian Real (BRL). He argues BRL is catching up with domestic rate markets and expects dips to find support given Brazil’s high yields and energy exporter status.
Brazilian Real catches up with rates
"The stronger US rate/dollar environment is starting to prove a headwind for some of the more popular emerging market plays, including the Brazilian real carry trade."
"Beyond the strong dollar environment, the local story sees President Lula’s approval ratings continue to widen over Flavio Bolsonaro and Brazil having to deal with the renewed threat of 25% US tariffs."
"In reality, however, it looks as though the Brazilian real is catching up with the local interest rate market, where short-dated rates have been selling off since late last week."
"Barring a massive spike in US yields and the dollar, which is not our baseline scenario, we expect the BRL to find good support on any dips given its high yield and net energy exporter status. Maybe the correction to 5.14 will be sufficient."
"At the start of the year, the market had been pricing the BACEN’s policy rate down at 12.50% from a 15.00% starting point. Now investors are considering the next BACEN move (off a 14.50% policy rate) to be a hike."
(This article was created with the help of an Artificial Intelligence tool and reviewed by an editor.)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Strategy (MSTR.US) officially removed from the MSCI index—what does this mean for crypto-related stocks?
Strategy has been officially removed from the MSCI index, with passive funds facing exit pressure. Crypto-related stocks are experiencing "significant" selling pressure.

Biotech Insider Trading in US Stocks Diverges: ImmunityBio (IBRX.US) Cashes Out the Most, Sellas (SLS.US) Director Bought In Before a 5x Surge
Insider trading in US-listed biotech companies shows divergence.
AI investment and consumer spending drive growth! UK Q3 GDP growth rate hits highest in two and a half years
As the widespread adoption of artificial intelligence (AI) continues to drive growth in corporate and consumer spending, and the economy demonstrates resilience in the face of an energy shock caused by the Iran war, the UK economy has achieved its fastest growth rate in two and a half years.

MSCI drops Strategy, Bitcoin eyes $70,000 as ETF outflows hit $300 million

